Literature DB >> 2893881

Reduced sensitivity of Plasmodium falciparum to mefloquine in West Africa.

F Simon, J Le Bras, C Gaudebout, P M Girard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893881     DOI： 10.1016/s0140-6736(88)91253-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

2.  Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal.

Authors:  I Hatin; J F Trape; F Legros; J Bauchet; J Le Bras
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

Review 3.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 4.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

5.  Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.

Authors:  Myriam Gharbi; Jennifer A Flegg; Véronique Hubert; Eric Kendjo; Jessica E Metcalf; Lionel Bertaux; Philippe J Guérin; Jacques Le Bras; Ahmed Aboubaca; Patrice Agnamey; Adela Angoulvant; Patricia Barbut; Didier Basset; Ghania Belkadi; Anne Pauline Bellanger; Dieudonné Bemba; Françoise Benoit-Vica; Antoine Berry; Marie-Laure Bigel; Julie Bonhomme; Françoise Botterel; Olivier Bouchaud; Marie-Elisabeth Bougnoux; Patrice Bourée; Nathalie Bourgeois; Catherine Branger; Laurent Bret; Bernadette Buret; Enrique Casalino; Sylviane Chevrier; Frédérique Conquere de Monbrison; Bernadette Cuisenier; Martin Danis; Marie-Laure Darde; Ludovic De Gentile; Jean-Marie Delarbre; Pascal Delaunay; Anne Delaval; Guillaume Desoubeaux; Michel Develoux; Jean Dunand; Rémy Durand; Odile Eloy; Nathalie Fauchet; Bernard Faugere; Alber Faye; Odile Fenneteau; Pierre Flori; Madeleine Fontrouge; Chantal Garabedian; Françoise Gayandrieu; Nadine Godineau; Pascal Houzé; Sandrine Houzé; Jean-Pierre Hurst; Houria Ichou; Laurence Lachaud; Agathe Lebuisson; Magalie Lefevre; Anne-Sophie LeGuern; Gwenaë Le Moal; Daniel Lusina; Marie-Claude Machouart; Denis Malvy; Sophie Matheron; Danièle Maubon; Denis Mechali; Bruno Megarbane; Guillaume Menard; Laurence Millon; Muriel Mimoun Aiach; Philippe Minodier; Christelle Morelle; Gilles Nevez; Philippe Parola; Daniel Parzy; Olivier Patey; Pierre Patoz; Pascale Penn; Alice Perignon; Stéphane Picot; Jean-Etienne Pilo; Isabelle Poilane; Denis Pons; Marie Poupart; Bruno Pradines; Didier Raffenot; Christophe Rapp; Marie-Catherine Receveur; Claudine Sarfati; Yaye Senghor; Fabrice Simon; Jean-Yves Siriez; Nicolas Taudon; Marc Thellier; Maxime Thouvenin; Dominique Toubas
Journal:  Malar J       Date:  2013-01-25       Impact factor: 2.979

6.  A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.

Authors:  Neils B Quashie; Nancy O Duah; Benjamin Abuaku; Lydia Quaye; Ruth Ayanful-Torgby; George A Akwoviah; Margaret Kweku; Jacob D Johnson; Naomi W Lucchi; Venkatachalam Udhayakumar; Christopher Duplessis; Karl C Kronmann; Kwadwo A Koram
Journal:  Malar J       Date:  2013-12-17       Impact factor: 2.979
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.